Sunday, March 12, 2023 5:44:06 PM
Safely used for 32 years for RA, repurposed drug for Covid19 and soon for Long Haul Covid19 and other respiratory viruses and Liver transplants. Now in the late stages of an FDA EUA phase Trial, where 710 people were already tested.
No better risk vs reward, over sold, massive upside drug stock in the sector right now, this close to approval... $RVVTF
Massive DD shared and debated here for 2.5 years for new folks to catch up on.... Enjoy
No better risk vs reward, over sold, massive upside drug stock in the sector right now, this close to approval... $RVVTF
Massive DD shared and debated here for 2.5 years for new folks to catch up on.... Enjoy
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
